Clinical data, real-world studies,
and health economic analyses of Apligraf®.
Apligraf is backed by extensive, reliable, and unmatched clinical and real-world evidence in both VLUs and DFUs.1-7
Only Apligraf has conducted randomized controlled trials (RCTs) resulting in FDA approval for the healing of VLUs and DFUs.1,5,7Clinical trials
Examine real-world observational studies that prove Apligraf closes more VLUs and DFUs faster.Real-world evidence
Health economic analyses
See how Apligraf has been shown to reduce VLU and DFU burden on patients and healthcare costs.Health economic studies
- Apligraf [package insert]. Canton, MA: Organogenesis Inc; 2017.
- Marston WA, et al. Wound Repair Regen. 2014;22(3):334-340.
- Treadwell T, et al. Adv Wound Care. 2018;7(3):69-76.
- Sabolinski ML, et al. J Comp Eff Res. 2018;7(8):797-805.
- Veves A, et al. Diabetes Care. 2001;24(2):290-295.
- Kirsner RS, et al. Wound Repair Regen. 2015;23(5):737-744.
- Data on file. Organogenesis Inc.